Adherence to and Acceptance of Once-Daily Tacrolimus after Kidney and Liver Transplant: Results from OSIRIS, a French Observational Study

Transplantation

Volumn 100, Issue 10, 2016, Pages 2099-2106

  Cassuto, Elisabeth ^a   Pageaux, Georges P ^b   Cantarovich, Diego ^c   Rostaing, Lionel ^d   Loupy, Alexandre ^e   Roche, Bruno ^f   Duvoux, Christophe ^g   Moreau, Karine ^h   Thervet, Eric ⁱ   Mazouz, Hakim ^j   Bourhis, Yann ^k   Dharancy, Sébastien ^l   Kessler, Michèle ^m  

^a PASTEUR HOSPITAL   (France)

^b HÔPITAL SAINT ELOI   (France)

^c NANTES UNIVERSITY HOSPITAL   (France)

^d CHU RANGUEIL   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f CHU Fort de France   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h BORDEAUX UNIVERSITY HOSPITAL   (France)

ⁱ HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^j AMIENS UNIVERSITY HOSPITAL   (France)

^k MAPI Institute   (France)

^l LILLE UNIVERSITY HOSPITAL   (France)

^m CHU NANCY BRABOIS   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRANCE; GLOMERULOPATHY; HUMAN; HYPERTENSION; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SCORING SYSTEM; URINARY TRACT DISEASE; AGED; CLINICAL TRIAL; DRUG ADMINISTRATION; MEDICATION COMPLIANCE; MIDDLE AGED; MULTICENTER STUDY; PATIENT ATTITUDE;

ADULT; AGED; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PROSPECTIVE STUDIES; TACROLIMUS;

EID: 84989320506     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000001307     Document Type: Article

References (36)

1. Agence de Biomédecine. Rapport annuel. http://www.agencebiomedecine. fr/rapport-annuel-2013lang=fr. Published 2013. Accessed April 28th, 2016.
2. ELTR. European Liver Transplant Registry. http://www.eltr.org/. Published 2012. Accessed April 28th, 2016.
3. Starzl TE, Todo S, Fung J, et al. FK 506 for liver, kidney, and pancreas transplantation. Lancet. 1989;2:1000-1004.
4. The U.S. Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl JMed. 1994; 331: 1110-1115.
5. Shapiro R, Young JB, Milford EL, et al. Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant. 2005;5:874-886.
6. Venkataramanan R, Swaminathan A, Prasad T, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995;29:404-430.
7. Venkataramanan R, Shaw LM, Sarkozi L, et al. Clinical utility of monitoring tacrolimus blood concentrations in liver transplant patients. J Clin Pharmacol. 2001;41:542-551.
8. Chisholm MA, Middleton MD. Modified-release tacrolimus. Ann Pharmacother. 2006;40:270-275.
9. Alloway R, Steinberg S, Khalil K, et al. Conversion of stable kidney transplant recipients from a twice daily Prograf-based regimen to a once daily modified release tacrolimus-based regimen. Transplant Proc. 2005;37:867-870.
10. Silva HT, Yang HC, Abouljoud M, et al. One-year results with extendedrelease tacrolimus/MMF, tacrolimus/MMF and cyclosporine/MMF in de novo kidney transplant recipients. Am J Transplant. 2007;7:595-608.
11. Krämer BK, Charpentier B, Bäckman L, et al. Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. Am J Transplant. 2010;10: 2632-2643.
12. World Health Organization. Sabate E. Adherence to Long-Term Therapies: Evidence for Action 2003.
13. Hansen R, Seifeldin R, Noe L. Medication adherence in chronic disease: issues in posttransplant immunosuppression. Transplant Proc. 2007;39: 1287-1300.
14. Fine RN, Becker Y, De Geest S, et al. Nonadherence consensus conference summary report. Am J Transplant. 2009;9:35-41.
15. Baines LS, Joseph JT, Jindal RM. Compliance and late acute rejection after kidney transplantation: a psycho-medical perspective. Clin Transplant. 2002;16:69-73.
16. Michelon TF, Piovesan F, Castilho C, et al. Non-compliance as a cause of renal graft loss. Transplant Proc. 2002;34:2768-2770.
17. Vlaminck H, Maes B, Evers G, et al. Prospective study on late consequences of subclinical noncompliance with immunosuppressive therapy in renal transplant patients. Am J Transplant. 2004;4:1509.
18. Morrissey PE, Reinert S, Yango A, et al. Factors contributing to acute rejection in renal transplantation: the role of noncompliance. Transplant Proc. 2005;37:2044-2047.
19. Osterberg L, Blaschke T. Adherence to medication. N Engl JMed. 2005; 353:487-497.
20. Mulazzi I, Cambou JP, Girerd X, et al. Six-item self-administered questionnaires in the waiting room: an aid to explain uncontrolled hypertension in high-risk patients seen in general practice. J Am Soc Hypertens. 2009; 3:221-227.
21. Girerd X, Hanon O, Anagnostopoulos K, et al. Assessment of antihypertensive compliance using a self-administered questionnaire: development and use in a hypertension clinic. Presse Med. 2001;30:1044-1048.
22. Laederach-Hofmann K, Bunzel B. Noncompliance in organ transplant recipients: a literature review. Gen Hosp Psychiatry. 2000;22:412-424.
23. Marant C, Longin J, Gauchoux R, et al. Long-termtreatment acceptance: what is it, and how can it be assessed Patient. 2012;5:239-249.
24. Arnould B, Gauchoux R, Meunier J, et al. Validation of accept, a new generic measure to assess how patients with chronic diseases balance between the advantages and disadvantages of following the recommended treatment regimen in real-life. Value Health. 2013;16:335.
25. Dew MA, DiMartini AF, De Vito Dabbs A, et al. Rates and risk factors for non-adherence to the medical regimen after adult solid organ transplantation. Transplantation. 2007;83:858-873.
26. Butler JA, Roderick P,Mullee M, et al. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77:769-776.
27. Raiz LR, Kilty KM, Henry ML, et al. Medication compliance following renal transplantation. Transplantation. 1999;68:51.
28. Lamba S, Nagurka R, Desai KK, et al. Self-reported nonadherence to immune-suppressant therapy in liver transplant recipients: demographic, interpersonal, and intrapersonal factors. Clin Transplant. 2012;26: 328-335.
29. Couzi L, Moulin B, Morin MP, et al. Factors predictive of medication nonadherence after renal transplantation: a French observational study. Transplantation. 2013;95:326-332.
30. Chisholm MA, Vollenweider LJ, Mulloy LL, et al. Renal transplant patient compliance with free immunosuppressive medications. Transplantation. 2000;70:1240.
31. Vasquez EM, Tanzi M, Benedetti E, et al. Medication noncompliance after kidney transplantation. Am J Health Syst Pharm. 2003;60:666-669.
32. Weng FL, Israni AK, JoffeMM, et al. Race and electronicallymeasured adherence to immunosuppressive medications after deceased donor renal transplantation. J Am Soc Nephrol. 2005;16:1839-1848.
33. O'Grady JG, Asderakis A, Bradley R, et al. Multidisciplinary insights into optimizing adherence after solid organ transplantation. Transplantation. 2010;89:627-632.
34. Butler JA, Peveler RC, Roderick P, et al. Measuring compliance with drug regimens after renal transplantation: comparison of self-report and clinician rating with electronic monitoring. Transplantation. 2004;77:786.
35. Schafer-Keller P, Steiger J, Bock A, et al. Diagnostic accuracy ofmeasurement methods to assess non-adherence to immunosuppressive drugs in kidney transplant recipients. Am J Transplant. 2008;8:616.
36. Denhaerynck K, Steiger J, Bock A, et al. Prevalence and risk factors of non-adherence with immunosuppressant medication in kidney transplant patients. Am J Transplant. 2007;7:108.